<DOC>
	<DOC>NCT02479971</DOC>
	<brief_summary>A prospective, randomized study will be performed in patients undergoing laparoscopic sleeve gastrectomy (LSG) as bariatric procedure. The patients will be randomized into 2 groups: those patients undergoing an intra-abdominal lavage with normal saline (Group 1) and those undergoing an intra-abdominal lavage with a gentamicin-clindamycin solution (Group 2). Postoperative pain and C reactive protein will be investigated 24 hours after surgery.</brief_summary>
	<brief_title>Effect of Peritoneal Lavage With Clindamycin-gentamicin on Laparoscopic Sleeve Gastrectomy</brief_title>
	<detailed_description>A prospective, randomized study will be performedin patients undergoing laparoscopic sleeve gastrectomy (LSG) as bariatric procedure. The patients will be randomized into 2 groups: those patients undergoing an intra-abdominal lavage with normal saline (Group 1) and those undergoing an intra-abdominal lavage with a gentamicin-clindamycin solution (Group 2). Postoperative pain and C reactive protein will be investigated 24 hours after surgery.</detailed_description>
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<mesh_term>Clindamycin</mesh_term>
	<mesh_term>Clindamycin palmitate</mesh_term>
	<mesh_term>Clindamycin phosphate</mesh_term>
	<mesh_term>Gentamicins</mesh_term>
	<criteria>Body mass index (BMI) &gt;40 Kg/m2 BMI &gt; 35 Kg/m2 with the presence of comorbidities associated to obesity Patients undergoing laparoscopic sleeve gastrectomy (LSG) as bariatric procedure. Gastroesophageal reflux Preoperative diagnosis of chronic renal failure Uncontrolled psychiatric disorders Active infections Malignancies Any other concomitant pathology considered as a contraindication for bariatric surgery.</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2015</verification_date>
</DOC>